目的 探讨染色体核型正常原发性急性髓系白血病(AML)和骨髓增生异常综合征(MDS)患者NPM基因突变。方法 染色体核型正常的原发性AML患者40例(28例为初治患者,12例位首次完全缓解期患者),MDS患者38例,用基因组DNA PCR法扩增NPM基因第12外显子,PCR产物纯化后直接测序,发现
doc.guandang.net
【摘要】目的 探讨染色体核型正常原发性急性髓系白血病(AML)和骨髓增生异常综合征(MDS)患者NPM基因突变。方法 染色体核型正常的原发性AML患者40例(28例为初治患者,12例位首次完全缓解期患者),MDS患者38例,用基因组DNA PCR法扩增NPM基因第12外显子,PCR产物纯化后直接测序,发现突变患者,将PCR产物克隆至pUCm-T载体,转化大肠杆菌 DH5α,至少挑选5个以上重组克隆,小量制备质粒后进行测序。结果 共发现NPM突变患者6例(AML 4例,MDS 2例),A型突变4例,B型突变1例,新发现突变1例(我们将之命名为R型)。结论 新发现了一个NPM突变类型并在国内外首次证实MDS患者也存在有NPM基因突变,为进一步研究NPM突变与AML及MDS发生的关系提供了重要的新线索。
【关键词】白血病,急性,髓系;骨髓增生异常综合征;NPM基因;突变
Studying of Nucleophosmin (NPM) gene mutations in patients with acute myeloid leukemia and myelodysplastic syndromes ZHANG Yue, ZHANG Mei-rong, YANG Lin, XIAO Zhi-jian. Institute of Hematology, Chinese Academe of Medical Sciences & Peking Union Medical College, Tianjin 300020, China
【Abstract】Objective To investigate Nucleophosmin (NPM) gene mutations in patients with primary acute myeloid leukemia(AML) and normal cytogenetics and in patients with primary myelodysplastic syndromes(MDS). Methods Genomic DNA corresponding to exon 12 of NPM gene were amplified by polymerase chain reaction(PCR) in 40 patients with primary AML and normal karyotype(28 cases were new diagnosed and 12 patients were in first remission)and 38 patients with MDS. The PCR products were purified and screened by direct sequencing, if mutations were found , the PCR products were cloned into a pUCm-T vector, then transfected into E.coil DH5α,at least 5 recombinant colonies were selected, and plasmid DNA were prepared and sequenced. Results NPM mutations were found in 6 patients (4 new diagnosed AML cases and 2 MDS cases), 4 were type A , 1 was type B, and 1 with novel sequence variant(we named it as type R) . Conclusion A new type of NPM mutation was found, and NPM mutations in patients with MDS were first demonstrated, and these results will supply new hints for the effects of NPM gene mutations in the pathogenesis of AML and MDS.
【Key words】Leukemia, acute, myeloid; Myelodysplastic Syndromes; NPM gene; Mutation
目的分析急性髓细胞白血病(AML)的NPM1(Nucleophosmin)基因第12外显子突变,探索...方法随机选择98份临床确诊的急性白血病和骨髓增生异常综合征(MDS)患者的冻存骨髓...
HAG方案治疗急性髓系白血病及骨髓增生异常综合征的临床研究_专业资料。目的评价HAG方案治疗复发难治性急性髓系白血病(AML)、老年AML及高危骨髓增生异常综合征(MDS)等...
骨髓增生异常综合征和急性髓系白血病患者骨髓间充质干细胞的生物学特性_专业资料。目的研究骨髓增生异常综合征(MDS)和急性髓系白血病(AML)患者的骨髓间充质干细胞...
乳腺 癌、肺癌和淋巴瘤等实体瘤,也包括急性髓系白血病(AML)和骨髓增生异常 综合征(MDS)这两个血液系统恶性肿瘤,最近,研究者们更加关注NPM基因 对急性白血病的...
最近在 核型正常的急性髓系白血病和少数骨髓增生异常综合征中发现有 NPM 基因突变及其蛋白的 胞浆移位,突变的 NPM 可能通过下调肿瘤抑制因子 Arf 启动 p53 活性...
携带β-地中海贫血基因的骨髓增生异常综合征转化为急性髓系白血病M6 1例报告和文献复习_专业资料。骨髓增生异常综合征(MDS)是一组起源于造血干细胞的获得性克隆性...
骨髓增生异常综合征_教学反思/汇报_教学研究_教育专区。骨髓增生异常综合征骨髓...有N-ras基因突变者 转为急性白血病的比 例较无突变者明显增加,生存期缩短。...
同时在血液病研究中,多数骨髓增生异常综合征 MDS 作为血液恶性肿瘤,在高危组的患者中,其治疗和急性髓系白血病是相同的,在全部 患者中大约 30%~40%的 MDS 患者...
论著? WT1 基因在骨髓增生异常综合征及急性 白血病患者中的表达陆滢 3 ,金洁 ,徐伟来浙江大学附属第一医院血液科 , 浙江大学血液病研究所 ,杭州 310006 摘要...
热门文档